Pazopanib in Elderly Patients — and Those With Other Illnesses

Age alone is not a reason to avoid pazopanib. Clinical guidance from NCCN and ESMO does not set an upper age limit for this drug. What your oncologist looks at is how well your liver, heart, kidneys, and blood pressure are functioning — these matter more than your age in years. Older patients may need closer monitoring and dose adjustments compared to younger patients, but many older adults take pazopanib throughout a full course of treatment without significant additional problems.

Liver disease is the condition that most directly changes how pazopanib is dosed. The drug is processed almost entirely by the liver, so if your liver is not working at full capacity, the usual starting amount can build up to levels that are harder to tolerate. Your oncologist will check your liver function with blood tests before you begin and review them at regular intervals. If the results show moderate liver impairment, a lower starting dose is recommended. In severe liver impairment, pazopanib is generally not used.

Very likely yes. Raised blood pressure is one of the most common effects of pazopanib, occurring in a large proportion of patients, and it tends to be more pronounced in people who already have hypertension. Your team will check your blood pressure at every visit. If it rises to a level that medicines cannot bring down, your oncologist may need to pause or reduce the dose. Having high blood pressure before you start is not a reason to avoid pazopanib — it is a reason to have it well controlled before you begin and to have a clear monitoring plan in place.

Mild to moderate kidney disease does not usually require a change to the starting dose of pazopanib. Unlike some cancer drugs removed mainly by the kidneys, pazopanib is primarily processed by the liver. Kidney function is still monitored throughout your treatment, particularly because pazopanib raises blood pressure, and persistent high blood pressure can put additional strain on kidneys that are already working below full capacity. Tell your oncologist what your kidney function results have been recently.

Tell your doctor about any history of heart rhythm problems, a prolonged QT interval on a previous heart tracing, heart failure, or a previous heart attack. Pazopanib can affect the electrical system of the heart in a way that is more significant if you already have a heart condition. Your team will likely arrange a heart tracing before you start and may repeat it during treatment. Medicines that also affect heart rhythm need to be reviewed before pazopanib begins, as combining them can increase the risk.

It depends on which medicines, and your oncologist or pharmacist will review the full list before you start. The biggest concerns are medicines broken down by the same liver enzyme as pazopanib, which can make the drug stronger or weaker than intended, and medicines that affect heart rhythm. Commonly reviewed medicines include certain antibiotics, antifungals, and blood pressure drugs. Never stop or change a medicine because of a possible interaction without checking with your team first — some interactions are managed with close monitoring rather than stopping either drug.

Possibly, especially in the first few months. Blood pressure, liver function, and thyroid levels need to be checked more regularly at the start of treatment, and your team may bring those check-ups closer together if you have other health conditions. After the first few treatment cycles, if everything is stable, visit frequency often returns to a routine schedule. Ask your team for the monitoring plan specific to your situation, so you know what to expect from the outset.

Report promptly: yellowing of your eyes or skin, which can indicate a liver reaction; a significant rise in your blood pressure or a persistent headache; unusual tiredness, swelling in the legs, or shortness of breath; and any unexpected bleeding. These do not always mean the drug has to stop, but each needs to be assessed quickly. Do not wait for your next scheduled appointment if any of these appear — call your team the same day.